Lipoprotein -- an independent risk factor for CVD

Area of Science:

• Cardiovascular Research
• Biochemistry
• Epidemiology

Background:

• Cerebrovascular disease (CVD) poses a significant global health challenge.
• Identifying novel risk factors for CVD is crucial for effective prevention strategies.
• Lipoprotein(a) [LP(a)] has emerged as a potential contributor to cardiovascular risk.

Purpose of the Study:

• To investigate the association between serum Lipoprotein(a) [LP(a)] levels and the risk of cerebrovascular disease (CVD).
• To determine if LP(a) is an independent risk factor for CVD, distinct from conventional lipid profiles.

Main Methods:

• A case-control study involving 150 subjects (120 CVD cases, 30 healthy controls) free from major comorbidities.
• Subjects were categorized into healthy controls, hemorrhagic CVD, and ischemic CVD groups.
• Serum LP(a) concentrations and lipid profiles were measured in all participants.

Main Results:

• Mean serum LP(a) concentrations were significantly higher in both hemorrhagic (31.9 ± 15.6 mg/dl) and ischemic CVD (44.8 ± 24.0 mg/dl) groups compared to healthy controls (17.6 ± 7.4 mg/dl).
• No significant differences in lipid profiles were observed between CVD cases and controls.
• Serum LP(a) concentrations showed no correlation with lipid profiles in CVD patients.

Conclusions:

• Elevated serum LP(a) is significantly associated with cerebrovascular disease.
• Lipoprotein(a) appears to be an independent risk factor for CVD.
• These findings highlight the importance of assessing LP(a) levels in CVD risk stratification.